key: cord-0755910-p15o3oja
authors: Makwe, Christian Chigozie; Okunade, Kehinde Sharafadeen; Rotimi, Muyiwa Kayode; Ekor, Oluwayemisi Esther; Oyeleke, Olalekan Gabriel; Bello, Qazeem Oladele; Oluwole, Ayodeji Ayotunde; Akase, Iorhen Ephraim; Ezenwa, Beatrice Nkoli; Fajolu, Iretiola Bamikeolu; Dada, Rotimi Williams; Oshodi, Yewande; Olatosi, John Olutola; Opanuga, Olabisi Oluranti; Omilabu, Sunday; Ezeaka, Veronica Chinyere; Afolabi, Bosede Bukola
title: Caesarean delivery of first prediagnosed COVID-19 pregnancy in Nigeria
date: 2020-06-16
journal: Pan Afr Med J
DOI: 10.11604/pamj.2020.36.100.23892
sha: b6eab1b98d221709f5e86d431c04e275e8fb07ee
doc_id: 755910
cord_uid: p15o3oja

The COVID-19 pandemic is currently causing widespread infection and deaths around the world. Since the identification of the first case in Nigeria in February 2020, the number of confirmed cases has risen to over 9,800. Although pregnant women are not necessarily more susceptible to infection by the virus, changes to their immune system in pregnancy may be associated with more severe symptoms. Adverse maternal and perinatal outcomes have been reported among pregnant women with COVID-19 infection. However, literature is scarce on the peripartum management and pregnancy outcome of a pregnant woman with COVID-19 in sub-Saharan Africa. We report the first successful and uncomplicated caesarean delivery of a pregnant woman with COVID-19 infection in Nigeria.

The novel coronavirus (COVID-19) was first identified in Wuhan City, Hubei province of China, towards the end of 2019 [1] . The COVID-19 pandemic is currently causing widespread infection and deaths around the world; with growing concern in the medical community [2] .

Globally, the number of confirmed cases has exceeded 5 million with hundreds of thousands of death [2] . Since the identification of the first case in Nigeria in February 2020, the number of confirmed cases has risen to over 9,855 as of May 30, 2020 [3] . The confirmatory test for and 10 in 1 and 5 minutes, respectively. Intraoperative oxygen saturation was maintained at a minimum of 98%, intraoperative infusion volume was 1000mL and estimated blood loss was 600mL.

She had prophylactic intravenous tranexamic acid 1g and carbetocin 100μg. The mother and baby were nursed in the recovery room of the operating theatre and the immediate postnatal period was uneventful.

The newborn was commenced on breast milk substitute until the mother was able to breastfeed the baby on demand. On day 3 after delivery, the mother and her newborn were transferred back to the isolation ward. The nasopharyngeal swabs collected from the neonate (at birth and 48 hours after birth) were all negative for COVID-19

infection. Both mother and baby remained asymptomatic during the postpartum period. On day 15 after delivery, the mother met the criteria for discharge because she had remained asymptomatic for more than 14 days after her initial positive result [4]. After appropriate counselling, the mother and her baby were discharged home and 

A novel coronavirus from patients with pneumonia in China

The authors declare no competing interests.